These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35962148)

  • 21. A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.
    Harrow A; Dryden R; McCowan C; Radley A; Parsons M; Thompson AM; Wells M
    BMJ Open; 2014 Jun; 4(6):e005285. PubMed ID: 24928595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
    Clancy C; Lynch J; OConnor P; Dowling M
    Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to adjuvant endocrine therapy among White British and ethnic minority breast cancer survivors in the United Kingdom.
    McGuinness S; Hughes L; Moss-Morris R; Hunter M; Norton S; Moon Z
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13722. PubMed ID: 36255032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.
    Quinn EM; Fleming C; O'Sullivan MJ
    Ir J Med Sci; 2016 May; 185(2):383-92. PubMed ID: 25971465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions, Attributions, and Emotions Toward Endocrine Therapy in Young Women with Breast Cancer.
    Walker HE; Rosenberg SM; Stanton AL; Petrie KJ; Partridge AH
    J Adolesc Young Adult Oncol; 2016 Mar; 5(1):16-23. PubMed ID: 26812461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.
    Spencer JC; Reeve BB; Troester MA; Wheeler SB
    Psychooncology; 2020 Apr; 29(4):647-654. PubMed ID: 32048400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
    Lambert LK; Balneaves LG; Howard AF; Gotay CC
    Breast Cancer Res Treat; 2018 Feb; 167(3):615-633. PubMed ID: 29110151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
    Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
    Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study
.
    Bourmaud A; Rousset V; Regnier-Denois V; Collard O; Jacquin JP; Merrouche Y; Lapoirie J; Tinquaut F; Lataillade L; Chauvin F
    Oncol Nurs Forum; 2016 May; 43(3):E94-E103. PubMed ID: 27105205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delay discounting and adjuvant endocrine therapy adherence in hormone receptor-positive breast cancer.
    Vaughn JE; Ammermann C; Lustberg MB; Bickel WK; Stein JS
    Health Psychol; 2021 Jun; 40(6):398-407. PubMed ID: 34323542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach.
    Janssen AM; Dam J; Prins J; Buffart LM; de Bruin M
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13721. PubMed ID: 36263723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
    Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
    Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
    Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV
    Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
    Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC
    Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant endocrine therapy in premenopausal breast cancer: a initial dedicated counseling: can it be useful for better adherence?].
    Lesur A; Dalenc F; Beguignot M
    Bull Cancer; 2019 Dec; 106(12S1):S28-S36. PubMed ID: 32008735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ageing perceptions and non-adherence to aromatase inhibitors among breast cancer survivors.
    Brier MJ; Chambless DL; Chen J; Mao JJ
    Eur J Cancer; 2018 Mar; 91():145-152. PubMed ID: 29329697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
    Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial.
    Walsh EA; Post K; Massad K; Horick N; Antoni MH; Penedo FJ; Safren SA; Partridge AH; Peppercorn J; Park ER; Temel JS; Greer JA; Jacobs JM
    Breast Cancer Res Treat; 2024 Apr; 204(3):547-559. PubMed ID: 38231313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income.
    Ursem CJ; Bosworth HB; Shelby RA; Hwang W; Anderson RT; Kimmick GG
    J Womens Health (Larchmt); 2015 May; 24(5):403-8. PubMed ID: 25884292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review.
    Fleming L; Agnew S; Peddie N; Crawford M; Dixon D; MacPherson I
    Breast; 2022 Aug; 64():63-84. PubMed ID: 35609380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.